Stocks-HTGM-HTG Molecular Diagnostics Inc

HTGM HTG Molecular Diagnostics Inc

4.69 -0.17 (-3.44%)
Delayed Prices By NASDAQ, in USD Market Open
Invest
Invest

Overview

Prev Close4.86
Day's Range 4.54 - 4.95
52 Week Range 2.15 - 33.93
Average Volume (3M)1.58M
1-Year Return-84.53%
Beta0.6867
Market Cap4.48M
P/E Ratio
Revenue6.8M
EPS-29.269
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.724/08/202204/11/202219/01/20235.007.5010.0012.5015.00
Chart times in UTC
Industry Miscellaneous Commercial Services
CEO John L. Lubniewski
Employees 87

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: HTG Molecular Diagnostics Inc's revenues increased by 4.19% and amounted to 8.91M. Net income increased by 17.85% to -17.15M. Net assets decreased by 28.20% to 10.40M and EPS increased from -4.51 to -2.47.
HTGM's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
42.75%
Net Profit Margin
-153.41%
Operating Margin
-311.71%
Return On Investment
-64.28%
12/21
03/22
06/22
09/22
Total Revenue
2.88M
1.18M
1.49M
1.25M
Gross Profit
1.52M
329.41K
477.11K
580.02K
Operating Income
-4.93M
-6.25M
-5.68M
-4.35M
Net Income
-5.19M
-6.5M
-5.89M
-4.52M